COVID-19: Bharat Biotech receives first batch of IIL's Covaxin substance
Hyderabad, Aug. 13 -- City-based Indian Immunological Limited (IIL) today handed over the first lot of Covaxin drug Substance to pharma company Bharat Biotech. Both organisations had earlier reached an agreement, under which IIL agreed to supply the substance required for the manufacturing the COVID-19 vaccine.
Dr. K. Anand Kumar, managing director of IIL handed over the first lot of Covaxin drug substance to Dr Krishna Ella, CMD, Bharat Biotech on Friday. The IIL, in a short period of time repurposed its manufacturing facility in Hyderabad, procured key raw materials consumables and key equipment for the process, completed the technology transfer, trials at R&D scale, training etc to manufacture the Covaxin substance.
"These activities...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.